US 10543222
Therapy for inhibition of single-stranded RNA virus replication
granted A61KA61K31/435A61K31/438
Quick answer
US patent 10543222 (Therapy for inhibition of single-stranded RNA virus replication) held by RedHill Biopharma Ltd. expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RedHill Biopharma Ltd.
- Grant date
- Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/435, A61K31/438, A61K31/4409, A61K31/7048